Treatment Plan for Psychopharmacology

Treatment Plan for Psychopharmacology

Increase Fluvoxamine to 50mg orally at bedtime.

Reason for the Selection

In four weeks when the patient revisited, there was a little improvement noted. He was reassessed, and the patient’s reaction to the medication was excellent with no sign of adverse side effects. It is vital to increase Fluvoxamine from 25mg to 50 mg orally at bedtime because the patient still having little problem embracing school and even handing the problem with handwashing. The dosage can be increased by 50 mg each four to seven day, until the point when the most extreme advantage is accomplished (Stahl, 2014). Fluoxetine has an elongated half-life of about 2–3 days, and its active metabolite an even elongated half-life of about two weeks. The long half-life is advantageous in that it seems to reduce the withdrawal reactions that are characteristic of sudden discontinuation of some SSRIs (Stahl 2014).

Expected Result with this Decision

The expected outcome was that Tyrel reacts appropriately to fluvoxamine 50mg at sleep time.

Fluvoxamine works by preventing the uptake of serotonin from the spaces between nerve cells subsequent its release, so the increase of Fluvoxamine will make more serotonin available in the areas to attach to other nerves and stimulate them. Tyler symptom will improve by next visit making him interact in school better and reduce his handwashing.

Difference between what you expected to achieve with Decision # 3

There will be no difference between the expected results and the negotiated outcome. Tyler will maintain the current dose of medication because he is feeling better and no complaint of side effect. Fluvoxamine is known to have a shorter half-life of 17-22 hours after a steady dose has been established (Stahl, 2014).

Ethical Considerations that might Impact Treatment Plan

Ethical concerns about the safety, acceptability, and humaneness of exposure therapy are essential to objections against the treatment. Beneficence and Nonmaleficence to take care to do no harm and protect the welfare and rights of the patient. The safety and tolerability of exposure therapy may be determined by evaluating the outcomes associated with this treatment. The treatment program that incorporates educating the family about OCD, its treatment, and how to adequately with the patient’s therapy would be valuable, given the high occurrence of relational issues in families of OCD patients (Altis, Elwood, & Olatunji, 2015).

Treatment Plan for Psychopharmacology

Increase Fluvoxamine to 50mg orally at bedtime.

Reason for the Selection

In four weeks when the patient revisited, there was a little improvement noted. He was reassessed, and the patient’s reaction to the medication was excellent with no sign of adverse side effects. It is vital to increase Fluvoxamine from 25mg to 50 mg orally at bedtime because the patient still having little problem embracing school and even handing the problem with handwashing. The dosage can be increased by 50 mg each four to seven day, until the point when the most extreme advantage is accomplished (Stahl, 2014). Fluoxetine has an elongated half-life of about 2–3 days, and its active metabolite an even elongated half-life of about two weeks. The long half-life is advantageous in that it seems to reduce the withdrawal reactions that are characteristic of sudden discontinuation of some SSRIs (Stahl 2014).

Expected Result with this Decision

The expected outcome was that Tyrel reacts appropriately to fluvoxamine 50mg at sleep time.

Fluvoxamine works by preventing the uptake of serotonin from the spaces between nerve cells subsequent its release, so the increase of Fluvoxamine will make more serotonin available in the areas to attach to other nerves and stimulate them. Tyler symptom will improve by next visit making him interact in school better and reduce his handwashing.

Difference between what you expected to achieve with Decision # 3

There will be no difference between the expected results and the negotiated outcome. Tyler will maintain the current dose of medication because he is feeling better and no complaint of side effect. Fluvoxamine is known to have a shorter half-life of 17-22 hours after a steady dose has been established (Stahl, 2014).

Ethical Considerations that might Impact Treatment Plan

Ethical concerns about the safety, acceptability, and humaneness of exposure therapy are essential to objections against the treatment. Beneficence and Nonmaleficence to take care to do no harm and protect the welfare and rights of the patient. The safety and tolerability of exposure therapy may be determined by evaluating the outcomes associated with this treatment. The treatment program that incorporates educating the family about OCD, its treatment, and how to adequately with the patient’s therapy would be valuable, given the high occurrence of relational issues in families of OCD patients (Altis, Elwood, & Olatunji, 2015).

 

Do you need a similar assignment done for you from scratch? We have qualified writers to help you. We assure you an A+ quality paper that is free from plagiarism. Order now for an Amazing Discount!
Use Discount Code “Newclient” for a 15% Discount!

NB: We do not resell papers. Upon ordering, we do an original paper exclusively for you.


The post Treatment Plan for Psychopharmacology appeared first on The Nursing TermPaper.

"Is this question part of your assignment? We Can Help!"

Essay Writing Service